| 1. |
鄭榮壽, 陳茹, 韓冰峰, 等. 2022年中國惡性腫瘤流行情況分析. 中華腫瘤雜志, 2024, 46(3): 221-231.
|
| 2. |
中華人民共和國國家衛生健康委員會醫政醫管局. 原發性肝癌診療指南(2022年版). 中國實用外科雜志, 2022, 42(3): 241-273.
|
| 3. |
孫文兵. 射頻消融治療肝細胞癌三十年: 學術地位困境與展望. 中華肝膽外科雜志, 2020, 26(6): 401-405.
|
| 4. |
Kanneganti M, Mahmud N, Kaplan DE, et al. Survival benefit of liver transplantation for hepatocellular carcinoma. Transplantation, 2020, 104(1): 104-112.
|
| 5. |
何文平, 黎璐璐, 隆成城, 等. 超聲引導下經皮微波消融治療對原發性肝癌患者肝功能、血管內皮功能和免疫功能的影響. 癌癥進展, 2023, 21(13): 1467-1470.
|
| 6. |
中華醫學會肝病學分會. 肝硬化診治指南. 實用肝臟病雜志, 2019, 22(6): 770-786.
|
| 7. |
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg, 2009, 250(2): 187-196.
|
| 8. |
Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2018, 29(Suppl 4): iv238-iv255. doi: 10.1093/annonc/mdy308.
|
| 9. |
Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol, 2022, 76(3): 681-693.
|
| 10. |
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol, 2018, 69(1): 182-236.
|
| 11. |
Poon RT, Cheung TT, Kwok PC, et al. Hong Kong consensus recommendations on the management of hepatocellular carcinoma. Liver Cancer, 2015, 4(1): 51-69.
|
| 12. |
中國抗癌協會腫瘤消融治療專業委員會, 中國臨床腫瘤學會(CSCO)腫瘤消融治療專家委員會, 中國醫師協會腫瘤消融治療技術專家組. CT引導下熱消融治療原發性肝癌中國專家共識. 中華內科雜志, 2023, 62(6): 647-660.
|
| 13. |
趙虎. 基于傾向性評分匹配的腹腔鏡肝門阻斷微波消融與經皮微波消融治療肝癌的療效比較. 成都: 成都醫學院, 2023.
|
| 14. |
Loriaud A, Denys A, Seror O, et al. Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems. Int J Hyperthermia, 2018, 34(8): 1171-1178.
|
| 15. |
沈強, 王能, 盛月紅, 等. 高功率微波消融治療近大血管肝細胞癌33例. 介入放射學雜志, 2012, 21(5): 391-394.
|
| 16. |
Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics,1985, 41(1): 103-116.
|
| 17. |
Xiong Y, Zhang Y, Hu C. Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis. Transl Cancer Res, 2024, 13(4): 1807-1820.
|
| 18. |
Vogl TJ, Martin SS, Gruber-Rouh T, et al. Comparison of microwave and radiofrequency ablation for the treatment of small- and medium-sized hepatocellular carcinomas in a prospective randomized trial. Rofo, 2024, 196(5): 482-490.
|
| 19. |
李楊, 李紅云, 劉從明. 超聲引導下射頻消融與大功率微波消融治療中晚期肝癌的療效對比研究. 中國醫學裝備, 2017, 14(6): 74-77.
|
| 20. |
林川, 王秋, 游昕. 射頻消融與微波消融聯合放療對伴門靜脈癌栓原發性肝癌患者的治療效果比較. 肝臟, 2021, 26(2): 167-170.
|
| 21. |
潘武, 強勇, 陽圓圓. 經皮微波消融與射頻消融治療肝癌的Meta分析. 醫學信息, 2024, 37(20): 20-27.
|
| 22. |
Han J, Fan YC, Wang K. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 2020, 99(43): e22703. doi: 10.1097/md.0000000000022703.
|